Results from a new large study have found that the diabetes drug Starlix (nateglinide) is not effective at slowing diabetes progression or reducing the risk of serious heart trouble in people at high risk for both heart disease and diabetes. Also in the study, researchers found that the blood pressure drug Diovan (valsartan) reduced the progression of diabetes by 14 percent when compared to a placebo, but it did not reduce the risk of serious cardiac problems such as stroke and heart attack in...
Read moreI've been asked a multitude of questions about drug allergies over the past 20 years. Most people do not get through life without having a... Read more »
Families of children with food allergies can tell you that, at times, it seems their whole day to day life revolves around accommodating... Read more »
Read Kathi's previous post on Anaphylaxis Medications are given to us to help ease symptoms or battle a health condition. They are meant... Read more »
Novartis Pharmaceuticals, maker of Diovan HCT, has announced that the FDA has granted approval of two higher dose formulations of Diovan HCT for the... Read more »
A new study in Japan has found that adding Diovan (valsartan) to blood-pressure drugs like calcium-channel blockers, ACE inhibitors, and beta... Read more »
A study of 1,668 patients who took the blood-pressure medication Diovan (valsartan) has found that Diovan helped lower both the patients' blood... Read more »
Researchers working with mice have found that the blood-pressure med Diovan may help reduce symptoms of Alzheimer's disease. In a recent study,... Read more »
This is a study to compare the effectiveness of Micardis HCT (telmisartan 80 mg/hydrochlorothiazide 25 mg) with Diovan HCT (valsartan 160 mg... Read more »